Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F
…, LR Bulkow, CE Homan, MM Snowball, HH Cagle… - Gastroenterology, 2007 - Elsevier
Background & Aims: Persistence of hepatitis B e antigen (HBeAg) in chronic hepatitis B has
been associated with increased risk for development of cirrhosis and hepatocellular …
been associated with increased risk for development of cirrhosis and hepatocellular …
Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F
…, CE Homan, MM Snowball, HH Cagle… - The Journal of …, 2007 - academic.oup.com
BackgroundThe development of hepatocellular carcinoma (HCC) in patients with chronic
hepatitis B virus (HBV) infection has been associated with specific HBV genotypes and the …
hepatitis B virus (HBV) infection has been associated with specific HBV genotypes and the …
Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers
…, CJ Christensen, BJ McMahon, LR Bulkow, HH Cagle… - Vaccine, 2001 - Elsevier
Introduction: Hepatitis B vaccination is recommended for all healthcare workers (HCW) at
risk of exposure to infectious body fluids. However, the absolute duration of protection from …
risk of exposure to infectious body fluids. However, the absolute duration of protection from …
Needle exchange and injection drug use frequency: a randomized clinical trial
DG Fisher, AM Fenaughty, HH Cagle… - JAIDS Journal of …, 2003 - journals.lww.com
Despite a lack of evidence that needle exchange programs (NEPs) cause an increase in
injection drug use, there are still concerns over fostering increased injection behavior with NEPs…
injection drug use, there are still concerns over fostering increased injection behavior with NEPs…
Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults
JL Williams, DA Bruden, HH Cagle, BJ McMahon… - Vaccine, 2003 - Elsevier
Current immunization schedules for hepatitis A vaccine specify administration of a booster
within 6–12 or 6–18 months of the primary dose. However, there may be circumstances that …
within 6–12 or 6–18 months of the primary dose. However, there may be circumstances that …
Estimating the date of hepatitis C virus infection from patient interviews and antibody tests on stored sera
…, DG Sullivan, DR Gretch, HH Cagle… - Official journal of the …, 2004 - journals.lww.com
OBJECTIVES Studies on the natural history and outcome of chronic hepatitis C virus (HCV)
infection differ regarding the proportion of persons who develop serious sequelae over time. …
infection differ regarding the proportion of persons who develop serious sequelae over time. …
[HTML][HTML] Hepatitis A prevalence among injection drug users
…, DG Fisher, AM Fenaughty, HH Cagle… - American Society for …, 2006 - clsjournal.ascls.org
OBJECTIVE: The purpose of this study was to develop a descriptive model of the association
between injection drug use and hepatitis A (HAV) in a sample of injection drug users (IDUs)…
between injection drug use and hepatitis A (HAV) in a sample of injection drug users (IDUs)…
“Crack” versus “rock” cocaine: the importance of local nomenclature in drug research and education
LJ Ouellet, HH Cagle… - Contemporary Drug …, 1997 - journals.sagepub.com
Whereas those who employ the various terms for smokable cocaine often assume the
presence of shared definitions, an inspection of the research literature on cocaine smoking and …
presence of shared definitions, an inspection of the research literature on cocaine smoking and …
Gonorrhea among drug users: An Alaskan versus a national sample
DM Paschane, DG Fisher, HH Cagle… - The American journal …, 1998 - Taylor & Francis
The study described here investigates the replicability of gender-specific risk profiles for
gonorrhea based on an Alaskan sample compared to a US national sample of drug users at risk …
gonorrhea based on an Alaskan sample compared to a US national sample of drug users at risk …
Telephone survey of Alaskan pharmacists' nonprescription needle-selling practices
CR Harbke, DG Fisher, HH Cagle, BN Trubatch… - Journal of Urban …, 2000 - Springer
Objectives To determine the availability of nonprescription needles and syringes (NS)
through pharmacy sales and to assess the impact of pharmacy policies and municipal …
through pharmacy sales and to assess the impact of pharmacy policies and municipal …